Cargando…
Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in China
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481427/ https://www.ncbi.nlm.nih.gov/pubmed/34966029 http://dx.doi.org/10.1097/CM9.0000000000001899 |
| _version_ | 1784791264924794880 |
|---|---|
| author | Yang, Yunfan Zhang, Yanli Jiang, Qian Meng, Li Li, Weiming Liu, Bingcheng Liu, Xiaoli Zhou, Li Liang, Rong Zhu, Xiaojian NaXu, Kuang, Pu Lin, Ting Zhu, Huanling |
| author_facet | Yang, Yunfan Zhang, Yanli Jiang, Qian Meng, Li Li, Weiming Liu, Bingcheng Liu, Xiaoli Zhou, Li Liang, Rong Zhu, Xiaojian NaXu, Kuang, Pu Lin, Ting Zhu, Huanling |
| author_sort | Yang, Yunfan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9481427 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94814272022-09-19 Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in China Yang, Yunfan Zhang, Yanli Jiang, Qian Meng, Li Li, Weiming Liu, Bingcheng Liu, Xiaoli Zhou, Li Liang, Rong Zhu, Xiaojian NaXu, Kuang, Pu Lin, Ting Zhu, Huanling Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2022-06-20 2022-08-03 /pmc/articles/PMC9481427/ /pubmed/34966029 http://dx.doi.org/10.1097/CM9.0000000000001899 Text en Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
| spellingShingle | Correspondence Yang, Yunfan Zhang, Yanli Jiang, Qian Meng, Li Li, Weiming Liu, Bingcheng Liu, Xiaoli Zhou, Li Liang, Rong Zhu, Xiaojian NaXu, Kuang, Pu Lin, Ting Zhu, Huanling Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in China |
| title | Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in China |
| title_full | Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in China |
| title_fullStr | Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in China |
| title_full_unstemmed | Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in China |
| title_short | Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in China |
| title_sort | safety of sars-cov-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in china |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481427/ https://www.ncbi.nlm.nih.gov/pubmed/34966029 http://dx.doi.org/10.1097/CM9.0000000000001899 |
| work_keys_str_mv | AT yangyunfan safetyofsarscov2vaccinesinpatientswithchronicmyeloidleukemiaamulticentersurveyinchina AT zhangyanli safetyofsarscov2vaccinesinpatientswithchronicmyeloidleukemiaamulticentersurveyinchina AT jiangqian safetyofsarscov2vaccinesinpatientswithchronicmyeloidleukemiaamulticentersurveyinchina AT mengli safetyofsarscov2vaccinesinpatientswithchronicmyeloidleukemiaamulticentersurveyinchina AT liweiming safetyofsarscov2vaccinesinpatientswithchronicmyeloidleukemiaamulticentersurveyinchina AT liubingcheng safetyofsarscov2vaccinesinpatientswithchronicmyeloidleukemiaamulticentersurveyinchina AT liuxiaoli safetyofsarscov2vaccinesinpatientswithchronicmyeloidleukemiaamulticentersurveyinchina AT zhouli safetyofsarscov2vaccinesinpatientswithchronicmyeloidleukemiaamulticentersurveyinchina AT liangrong safetyofsarscov2vaccinesinpatientswithchronicmyeloidleukemiaamulticentersurveyinchina AT zhuxiaojian safetyofsarscov2vaccinesinpatientswithchronicmyeloidleukemiaamulticentersurveyinchina AT naxu safetyofsarscov2vaccinesinpatientswithchronicmyeloidleukemiaamulticentersurveyinchina AT kuangpu safetyofsarscov2vaccinesinpatientswithchronicmyeloidleukemiaamulticentersurveyinchina AT linting safetyofsarscov2vaccinesinpatientswithchronicmyeloidleukemiaamulticentersurveyinchina AT zhuhuanling safetyofsarscov2vaccinesinpatientswithchronicmyeloidleukemiaamulticentersurveyinchina |